According to a 2005 study in the New England Journal of Medicine, most major drugs are effective in only 25% – 60% of the population. We now know that many of these failures are entirely due to the performance of an individual’s drug-metabolizing enzymes, controlled by their genes.
Healthcare providers have the ability like never before to improve outcomes while significantly reducing overall healthcare costs.
By working with RxGenomix, providers gain access to the information they need to make the best possible prescribing decisions for each patient, based on their unique genetics. And by combining pharmacogenomic testing with the input of a pharmacist trained in pharmacogenomics, prescribers can create a truly personalized medication plan for each patient. This will:
- Allow prescribing of optimal medications and with much greater speed
- Reduce serious or even fatal adverse drug events
- Improve patient outcomes
- Reduce medication usage
- Reduce overall medical expenses
PGx testing is a reliable predictive test for pharmacotherapy and, with total annual prescription drug spending nearing $400 billion in the U.S., we simply can’t afford to be guessing anymore.